Evidence map›Paper›PMID 29769214›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

Tumor-Infiltrating Lymphocytes and Colorectal Cancer Survival in African American and Caucasian Patients.

Kristin Wallace, David N Lewin, Shaoli Sun, Clayton M Spiceland, Don C Rockey, Alexander V Alekseyenko, Jennifer D Wu, John A Baron, Anthony J Alberg, Elizabeth G Hill

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer.International journal of biological sciences · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. WMicrobiome · 2019
    Article
  20. TFrontiers in oncology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kristin WallaceHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina. wallack@musc.edu.
David N LewinHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
Shaoli SunHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
Clayton M SpicelandDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Don C RockeyDepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Alexander V AlekseyenkoHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
Jennifer D WuFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
John A BaronDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Anthony J AlbergHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
Elizabeth G HillHollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.
Medical University of South Carolina · USNorthwestern University · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
South Carolina Cancer Disparities Research Center (SC CADRE)U54CA210962 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FORD, MARVELLA ELIZABETH, SALLEY, JUDITH · 2017 to 2023
$6.7M
South Carolina Cancer Disparities Research Center (SC CaDRe)U54CA210963 · NCI · SOUTH CAROLINA STATE UNIVERSITY · PI FORD, MARVELLA ELIZABETH, SALLEY, JUDITH · 2017 to 2023
$6.1M
Tumor immune and glycan biomarkers for progressive prostate cancerR01CA212409 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ABDULKADIR, SARKI A., DRAKE, RICHARD R. · 2018 to 2022
$2.7M
Target MIC shedding to revive anti-tumor immunityR01CA204021 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, JENNIFER D · 2016 to 2022
$1.8M
NKG2D superagonist co-stimulation to enhance adaptive immunotherapy of cancerR01CA208246 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, JENNIFER D · 2016 to 2020
$1.8M
Targeting MIC shedding to revive host NKG2D-mediated immune response in prostateR01CA149405 · NCI · UNIVERSITY OF WASHINGTON · PI WU, JENNIFER D · 2010 to 2014
$1.5M
Modeling MIC Shedding in Prostate Cancer ProgressionK01CA116002 · NCI · UNIVERSITY OF WASHINGTON · PI WU, JENNIFER D · 2005 to 2009
$698k
Race, pathomolecular signature and colorectal cancer survivalK07CA151864 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WALLACE, KRISTIN · 2011 to 2015
$649k
Race, prognostic markers and survival in early and late-onset colorectal cancerR03CA156668 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WALLACE, KRISTIN · 2012 to 2013
$143k
NCATS NIH HHS UL1 TR001450NCI NIH HHS K01 CA116002NCI NIH HHS K07 CA151864NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA149405NCI NIH HHS R01 CA204021NCI NIH HHS R01 CA208246NCI NIH HHS R01 CA212409NCI NIH HHS R03 CA156668NCI NIH HHS U54 CA210962NCI NIH HHS U54 CA210963
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedBlack or African AmericanColorectal NeoplasmsFemaleHumansLymphocytes, Tumor-InfiltratingMaleMiddle AgedPrognosisSurvival RateWhite People

Identifiers

PMID29769214
PMCPMC6449046
OpenAlexW2803979459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.